In addition, studies in HCCs and bladder cancers have demonstrated that miR-101 is epigenetically repressed by EZH2-mediated histone modification (10,24), which may also lead to the aberrant regulation of AP-1 signaling by miR-101. This evidence concerns the gene JUN and urinary bladder carcinoma.